Related Experiment Video
Updated: Sep 3, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis
Oscar Hou In Chou1, Jonathan Mui1, Cheuk To Chung1
1Epidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
Insights
Carditis is a rare side effect of COVID-19 vaccination in young people, occurring at a rate of approximately 38 per million doses. Most cases are mild and resolve quickly, with higher rates observed in males and after the second dose.
Area of Science:
- Cardiology
- Vaccinology
- Public Health
Background:
- COVID-19 vaccination has been linked to carditis, particularly in pediatric males.
- Global rates of post-vaccination carditis in children and adolescents require systematic investigation.
Purpose of the Study:
- To conduct a systematic review and meta-analysis to determine the incidence of carditis in pediatric and adolescent populations following COVID-19 vaccination.
Main Methods:
- Searched PubMed, Embase, and Latin American databases for relevant studies.
- Extracted event counts and at-risk populations; calculated rate ratios per million doses.
- Performed subgroup analysis based on vaccine dose and patient demographics.
Main Results:
- Analyzed 39 studies involving 12,602,625 COVID-19 vaccine doses, identifying 343 carditis cases (pooled rate: 37.76/million).
- Carditis rates were higher in males (rate ratio: 5.04) and after the second vaccine dose (rate ratio: 5.60).
- Most cases (99.67%) resolved, with common symptoms including chest pain, ECG abnormalities, and myocardial edema on CMR.
Conclusions:
- Post-COVID-19 vaccination carditis is rare in children and adolescents globally.
- The majority of carditis episodes are self-limiting with rapid symptom resolution.
- Balancing vaccine benefits against rare risks like carditis is crucial.
Background:
Coronavirus Disease-2019 (COVID-19) vaccination has been associated with the development of carditis, especially in children and adolescent males. However, the rates of these events in the global setting have not been explored in a systematic manner. The aim of this systematic review and meta-analysis is to investigate the rates of carditis in children and adolescents receiving COVID-19 vaccines.
Methods:
PubMed, Embase and several Latin American databases were searched for studies. The number of events, and where available, at-risk populations were extracted. Rate ratios were calculated and expressed as a rate per million doses received. Subgroup analysis based on the dose administered was performed. Subjects ≤ 19 years old who developed pericarditis or myocarditis following COVID-19 vaccination were included.
Results:
A total of 369 entries were retrieved. After screening, 39 articles were included. Our meta-analysis found that 343 patients developed carditis after the administration of 12,602,625 COVID-19 vaccination doses (pooled rate per million: 37.76; 95% confidence interval [CI] 23.57, 59.19). The rate of carditis was higher amongst male patients (pooled rate ratio: 5.04; 95% CI 1.40, 18.19) and after the second vaccination dose (pooled rate ratio: 5.60; 95% CI 1.97, 15.89). In 301 cases of carditis (281 male; mean age: 15.90 (standard deviation [SD] 1.52) years old) reported amongst the case series/reports, 261 patients were reported to have received treatment. 97.34% of the patients presented with chest pain. The common findings include ST elevation and T wave abnormalities on electrocardiography. Oedema and late gadolinium enhancement in the myocardium were frequently observed in cardiac magnetic resonance imaging (CMR). The mean length of hospital stay was 3.91 days (SD 1.75). In 298 out of 299 patients (99.67%) the carditis resolved with or without treatment.
Conclusions:
Carditis is a rare complication after COVID-19 vaccination across the globe, but the vast majority of episodes are self-limiting with rapid resolution of symptoms within days. Central illustration. Balancing the benefits of vaccines on COVID-19-caused carditis and post-vaccination carditis.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis I: Introduction
Pericarditis I: Introduction
Endocarditis III: Medical Management

